Delivery Order SPE2DB24D1205-SPE2DB25FCRLQ
Award Date
11/6/24
Potential Completion Date
11/7/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,230.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 22, 2023. The contract was not set aside for any specific business category....
This federal contract award, valued at $2,463.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, with a completion date of January 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $7,705.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, with a completion date of April 21, 2025. The contract type is Firm Fixed Price, and it is not designated as a set-aside. Additionally, AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,473.19 firm fixed-price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $6,117.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a completion date of February 11, 2025. The contract is a Delivery Order and has a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,813.97, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical supply. The contract has an ultimate completion date of July 16, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML. The $5,897.50 firm-fixed-price delivery order has an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999.42, is a Firm Fixed Price Delivery Order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML. The $1,158.72 firm-fixed-price delivery order has an ultimate completion date of November 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...